1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. IGEA Pharma N.V.
  6. News
  7. Summary
    IGPH   NL0012768675

IGEA PHARMA N.V.

(IGPH)
  Report
Delayed Swiss Exchange  -  07:29 2022-06-27 am EDT
0.1170 CHF    0.00%
06/26IGEA PHARMA N : Notice to postpone annual general meeting IGEA Pharma N.V.
PU
06/15IGEA PHARMA N : Note of the Board
PU
06/15IGEA PHARMA N.V. : IGEA to get SIX further approval to the 2021 annual report disclosure
EQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

IGEA Pharma Gets Swiss Bourse Approval To Delay FY21 Annual Report Publication

05/02/2022 | 03:00am EDT


© MT Newswires 2022
All news about IGEA PHARMA N.V.
06/26IGEA PHARMA N : Notice to postpone annual general meeting IGEA Pharma N.V.
PU
06/15IGEA PHARMA N : Note of the Board
PU
06/15IGEA PHARMA N.V. : IGEA to get SIX further approval to the 2021 annual report disclosure
EQ
06/08Igea Pharma Secures $6 Million Funds To Complete Cannabidiol Extraction Facility
MT
06/07IGEA PHARMA N.V. : Igea pharma has signed a preliminary agreement with lmh-an industrial h..
EQ
05/02IGEA Pharma Gets Swiss Bourse Approval To Delay FY21 Annual Report Publication
MT
05/02IGEA PHARMA N.V. : IGEA to get SIX approval to delay the 2021 annual report disclosure
EQ
05/01IGEA PHARMA N : to get SIX approval to delay the 2021 annual report disclosure
PU
02/01IGEA PHARMA N : non-executive board members resigned after completion of the first post-co..
PU
2021IGEA PHARMA N : GBC Research report IGEA Pharma N.V.
PU
More news
Financials
Sales 2021 0,14 M 0,15 M 0,15 M
Net income 2021 - - -
Net Debt 2021 - - -
P/E ratio 2021 -
Yield 2021 -
Capitalization 39,2 M 41,3 M 41,3 M
Capi. / Sales 2021 280x
Capi. / Sales 2022 0,77x
Nbr of Employees 2
Free-Float 14,4%
Chart IGEA PHARMA N.V.
Duration : Period :
IGEA Pharma N.V. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Last Close Price 0,12 €
Average target price 1,05 €
Spread / Average Target 804%
Managers and Directors
Vicenzo Moccia Chairman-Management Board